Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
930studies shown
Showing 481-492 of 930
Drug study icon
WithdrawnNCT00204503

Depakote ER in people with Bipolar I or II Depression and Alcohol Abuse or Dependence

This study was withdrawn in the United States. It focuses on depression.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Medical Branch, Galveston
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00322764

RG2417 for depression

This study is completed in the United States. It is testing RG2417 for depression.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Repligen Corporation
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT00835120

Pioglitazone for Bipolarity and Comorbid Metabolic Syndrome or Insulin Resistance

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity, Depression
Drug study icon
Active Not RecruitingNCT05065294

Psilocybin Therapy for Depression in Bipolarity type II

This study is looking at determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolarity II. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00411463

Psychotherapy for Bipolar II Depression, Study, Phase II

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity, Depression
Drug study icon
Active Not RecruitingNCT06869187

ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolarity in Adults

This study is looking at whether ABX-002 can help people with bipolarity Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Autobahn Therapeutics, Inc.
Condition
Bipolarity, Depression
Drug study icon
Active Not RecruitingNCT03748446

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolarity

This study is comparing Xenon with placebo for people with depression or Depression in bipolarity. Participants receive Xenon or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression, Bipolarity
Behavioral study icon
SuspendedNCT02719392

A Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Depression in bipolarity

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00762268

A study of SAMe for Treatment-Resistant Depression in bipolarity

This study exists to see whether the medication SAMe can play a useful role in care. Researchers are trying to understand what the medication SAMe could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.